Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Oct;90(4):1406–1413. doi: 10.1172/JCI116007

Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin.

J Nip 1, H Shibata 1, D J Loskutoff 1, D A Cheresh 1, P Brodt 1
PMCID: PMC443186  PMID: 1383272

Abstract

Human melanoma is a highly metastatic cancer and the regional lymph nodes are generally the first site of metastasis. Adhesion to cryostat sections of human lymph nodes was therefore studied using two human melanoma models established from lymph node metastases, namely, MeWo cell lines of diverse metastatic potentials and a highly metastatic cell line of recent origin designated MIM/8. We found a good correlation between the metastatic potentials of the melanoma cells as measured in nude mice and their ability to adhere to cryostat sections of human lymph nodes. When adhesion to immobilized extracellular matrix proteins was measured, a significant increase in adhesion, which correlated with increased metastasis, was seen mainly on vitronectin and to a lesser extent on fibronectin. The adhesion to vitronectin and to the frozen sections were specifically blocked by an RGD-containing peptide, mAb 661 to vitronectin and mAb LM609 to integrin alpha v beta 3. FACS analysis revealed a significant and specific increase in cell surface expression of alpha v beta 3 on the metastatic cells as compared to the parent line. Together these results suggest that the adhesion of melanoma cells to lymph node vitronectin via the alpha v beta 3 receptor plays a role in the process of lymphatic dissemination.

Full text

PDF
1406

Images in this article

1408Image
on p.1408
1410Image
on p.1410
1412Image
on p.1412
1412Image
on p.1412

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Buck C. A. Integrins and other cell adhesion molecules. FASEB J. 1990 Aug;4(11):2868–2880. [PubMed] [Google Scholar]
  2. Albelda S. M., Mette S. A., Elder D. E., Stewart R., Damjanovich L., Herlyn M., Buck C. A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990 Oct 15;50(20):6757–6764. [PubMed] [Google Scholar]
  3. Auerbach R., Lu W. C., Pardon E., Gumkowski F., Kaminska G., Kaminski M. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res. 1987 Mar 15;47(6):1492–1496. [PubMed] [Google Scholar]
  4. Boukerche H., Berthier-Vergnes O., Bailly M., Doré J. F., Leung L. L., McGregor J. L. A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood. 1989 Aug 15;74(3):909–912. [PubMed] [Google Scholar]
  5. Brodt P. Adhesion mechanisms in lymphatic metastasis. Cancer Metastasis Rev. 1991 May;10(1):23–32. doi: 10.1007/BF00046841. [DOI] [PubMed] [Google Scholar]
  6. Brodt P., Fallavollita L., Sawka R. J., Shibata P., Nip J., Kim U., Shibata H. Tumor cell adhesion to frozen lymph node sections--a correlate of lymphatic metastasis in breast carcinoma models of human and rat origin. Breast Cancer Res Treat. 1990 Dec;17(2):109–120. doi: 10.1007/BF01806291. [DOI] [PubMed] [Google Scholar]
  7. Brodt P., Parhar R., Sankar P., Lala P. K. Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int J Cancer. 1985 Feb 15;35(2):265–273. doi: 10.1002/ijc.2910350220. [DOI] [PubMed] [Google Scholar]
  8. Brodt P. Tumor cell adhesion to frozen lymph node sections--an in vitro correlate of lymphatic metastasis. Clin Exp Metastasis. 1989 May-Jun;7(3):343–352. doi: 10.1007/BF01753685. [DOI] [PubMed] [Google Scholar]
  9. Carter W. G., Wayner E. A., Bouchard T. S., Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol. 1990 Apr;110(4):1387–1404. doi: 10.1083/jcb.110.4.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cheresh D. A., Spiro R. C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987 Dec 25;262(36):17703–17711. [PubMed] [Google Scholar]
  11. Dedhar S. Integrins and tumor invasion. Bioessays. 1990 Dec;12(12):583–590. doi: 10.1002/bies.950121205. [DOI] [PubMed] [Google Scholar]
  12. Fidler I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 1975 Jan;35(1):218–224. [PubMed] [Google Scholar]
  13. Hayman E. G., Pierschbacher M. D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4003–4007. doi: 10.1073/pnas.80.13.4003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kramer R. H., Rosen S. D., McDonald K. A. Basement-membrane components associated with the extracellular matrix of the lymph node. Cell Tissue Res. 1988 May;252(2):367–375. doi: 10.1007/BF00214379. [DOI] [PubMed] [Google Scholar]
  15. Li L., Price J. E., Fan D., Zhang R. D., Bucana C. D., Fidler I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst. 1989 Sep 20;81(18):1406–1412. doi: 10.1093/jnci/81.18.1406. [DOI] [PubMed] [Google Scholar]
  16. Marshall J. F., Nesbitt S. A., Helfrich M. H., Horton M. A., Polakova K., Hart I. R. Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer. 1991 Dec 2;49(6):924–931. doi: 10.1002/ijc.2910490621. [DOI] [PubMed] [Google Scholar]
  17. Nomura Y., Tashiro H., Hisamatsu K. In vitro clonogenic growth and metastatic potential of human operable breast cancer. Cancer Res. 1989 Oct 1;49(19):5288–5293. [PubMed] [Google Scholar]
  18. Reilly J. T., Nash J. R. Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue. J Clin Pathol. 1988 Dec;41(12):1269–1272. doi: 10.1136/jcp.41.12.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ruoslahti E., Giancotti F. G. Integrins and tumor cell dissemination. Cancer Cells. 1989 Dec;1(4):119–126. [PubMed] [Google Scholar]
  20. Saiga T., Ohbayashi T., Tabuchi K., Midorikawa O. A model for tumorigenicity and metastatic potential: growth in 1.0% agar cultures. In Vitro Cell Dev Biol. 1987 Dec;23(12):850–854. doi: 10.1007/BF02620964. [DOI] [PubMed] [Google Scholar]
  21. Salmon S. E., Liu R. Direct "wet" staining of tumour or haematopoietic colonies in agar culture. Br J Cancer. 1979 Jun;39(6):779–781. doi: 10.1038/bjc.1979.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tohgo A., Tanaka N. G., Ogawa H. Platelet-aggregating activities of metastasizing tumor cells. IV. Effects of cell surface modification on thrombin generation, platelet aggregation and subsequent lung colonization. Invasion Metastasis. 1986;6(1):58–68. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES